Jazz Pharmaceuticals JAZZ paid Tiber Creek Group $50K for lobbying in Q4 2025 · Health Issues, Medical and 1 more issue

Trade details

Type: Lobbying report
Amount: $50,000
Quarter: Q4 2025
Stock: Jazz Pharmaceuticals JAZZ
Client: Jazz Pharmaceuticals
Reported: 26/01/17

Up 0.0% from last quarter

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Jazz Pharmaceuticals's other lobbying reports

Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$80K
$80K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$490K
$490K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
Lobbying
Jazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/19
for Q2

Jazz Pharmaceuticals JAZZ paid Tiber Creek Group $50K for lobbying in Q4 2025 · Health Issues, Medical and 1 more issue | Whalegun